Dendritic cell-derived IL-2 production is regulated by IL-15 in humans and in mice.

Dendritic cells (DCs) are involved in the initiation and regulation of innate and adaptive immune responses. Several molecular mechanisms regulate these diverse DC functions, and we have previously reported that mouse dendritic cells (mDCs) can produce interleukin-2 (IL-2) in vitro and in vivo, in response to microbial activation and T-cell-mediated stimuli. This property is shared by different DC subtypes, including Langerhans cells. Here we show that, on appropriate stimulation, human DCs, both plasmacytoid and myeloid subtypes, also express IL-2. Interestingly, the production of IL-2 by myeloid DCs is induced by T-cell-mediated stimuli and depends on the presence of IL-15. The key role of this cytokine in regulating IL-2 production was also confirmed in the mouse system. In particular, we could show that DCs from IL-15-deficient mice were strongly impaired in the ability to produce IL-2 after interactions with different microbial stimuli. Our results indicate that DC-produced IL-2 is tightly coregulated with the expression of IL-15.

[1]  S. Koyasu,et al.  Critical role of IL-15–IL-15R for antigen-presenting cell functions in the innate immune response , 2001, Nature Immunology.

[2]  T. Waldmann,et al.  IL-15Rα Recycles and Presents IL-15 In trans to Neighboring Cells , 2002 .

[3]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[4]  J. Banchereau,et al.  Interleukin 15 Skews Monocyte Differentiation into Dendritic Cells with Features of Langerhans Cells , 2001, The Journal of experimental medicine.

[5]  Meredith O'Keeffe,et al.  Human and mouse plasmacytoid dendritic cells. , 2002, Human immunology.

[6]  T. Strom,et al.  IL-15 and IL-2: a matter of life and death for T cells in vivo , 2001, Nature Medicine.

[7]  P. Ricciardi-Castagnoli,et al.  Dendritic cells directly trigger NK cell functions: Cross-talk relevant in innate anti-tumor immune responses in vivo , 1999, Nature Medicine.

[8]  Noguchi,et al.  Interleukin‐15 production at the early stage after oral infection with Listeria monocytogenes in mice , 1999, Immunology.

[9]  P. Morrissey,et al.  Reversible Defects in Natural Killer and Memory Cd8 T Cell Lineages in Interleukin 15–Deficient Mice , 2000, The Journal of experimental medicine.

[10]  T. Waldmann,et al.  IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. , 1996, Immunity.

[11]  P. Ohashi,et al.  Differential Roles of Interleukin 15 mRNA Isoforms Generated by Alternative Splicing in Immune Responses in Vivo , 2000, The Journal of experimental medicine.

[12]  N. Copeland,et al.  Functional Characterization of the Human Interleukin-15 Receptor αChain and Close Linkage of IL15RA and IL2RA Genes (*) , 1995, The Journal of Biological Chemistry.

[13]  K. Rajewsky,et al.  Development and proliferation of lymphocytes in mice deficient for both interleukins‐2 and ‐4 , 1994, European journal of immunology.

[14]  T. Waldmann The IL-2/IL-15 Receptor Systems: Targets for Immunotherapy , 2002, Journal of Clinical Immunology.

[15]  P. Ricciardi-Castagnoli,et al.  Infection of dendritic cells by murine cytomegalovirus induces functional paralysis , 2001, Nature Immunology.

[16]  T. Waldmann,et al.  IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[17]  N. Pavelka,et al.  A Contribution of Mouse Dendritic Cell–Derived IL-2 for NK Cell Activation , 2004, The Journal of experimental medicine.

[18]  E. Jaffee,et al.  Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Maria Persico,et al.  Inducible IL-2 production by dendritic cells revealed by global gene expression analysis , 2001, Nature Immunology.

[20]  F. Sallusto,et al.  Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha , 1994, The Journal of experimental medicine.

[21]  Y. Yoshikai,et al.  The role of interleukin 15 in mounting an immune response against microbial infections. , 2000, Microbes and infection.

[22]  Giovanni Melioli,et al.  Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells , 2002, The Journal of experimental medicine.

[23]  F. Belardelli,et al.  IL-15 Is Expressed by Dendritic Cells in Response to Type I IFN, Double-Stranded RNA, or Lipopolysaccharide and Promotes Dendritic Cell Activation1 , 2001, The Journal of Immunology.

[24]  P. Gane,et al.  IL-13 induces CD34+ cells isolated from G-CSF mobilized blood to differentiate in vitro into potent antigen presenting cells. , 1997, Journal of immunological methods.

[25]  T. Whiteside,et al.  Cancer immunotherapy with interleukin-2-activated natural killer cells , 2002, Molecular biotechnology.

[26]  M. Mohamadzadeh,et al.  Ultraviolet B radiation up-regulates the expression of IL-15 in human skin. , 1995, Journal of immunology.

[27]  P. Ricciardi-Castagnoli,et al.  Early IL-2 Production by Mouse Dendritic Cells Is the Result of Microbial-Induced Priming1 , 2003, The Journal of Immunology.

[28]  T. Waldmann,et al.  Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy. , 2001, Immunity.

[29]  R. Paxton,et al.  IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. , 1995, Journal of immunology.

[30]  T. Waldmann,et al.  The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. , 1999, Annual review of immunology.

[31]  A. Enk,et al.  Pro‐inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum‐free conditions , 1997, European journal of immunology.

[32]  N. Kadowaki,et al.  The nature of the principal type 1 interferon-producing cells in human blood. , 1999, Science.